SomaLogic, Inc. (SLGC) Tops Q2 EPS by 3c, Revenues Miss; Guides Lower

SomaLogic, Inc. (NASDAQ: SLGC) reported Q2 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $14.1 million versus the consensus estimate of $24.83 million.

GUIDANCE:

SomaLogic, Inc. sees FY2022 revenue of $80-90 million, versus the consensus of $106.95 million.

For earnings history and earnings-related data on SomaLogic, Inc. (SLGC) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Ferrari completes €250M buyback tranche, launches third
• Why UBS thinks this European chipmaker is still undervalued despite its premium valuation